Laboratorios Farmaceuticos Rovi, S.A. (VIE:ROVI)
Austria · Delayed Price · Currency is EUR 73.00
-0.65 (-0.88%)
Last updated: Jan 28, 2026, 1:00 PM CET
VIE:ROVI Revenue
Laboratorios Farmaceuticos Rovi had revenue of 210.47M EUR in the quarter ending September 30, 2025, a decrease of -10.54%. This brings the company's revenue in the last twelve months to 724.20M, down -9.39% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M, down -7.93%.
Revenue (ttm)
724.20M
Revenue Growth
-9.39%
P/S Ratio
5.19
Revenue / Employee
329.63K
Employees
2,188
Market Cap
3.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UNIQA Insurance Group AG | 7.42B |
| Telekom Austria AG | 5.46B |
| Wienerberger AG | 4.64B |
| Österreichische Post AG | 3.11B |
| EVN AG | 3.05B |
| DO & CO Aktiengesellschaft | 2.40B |
| Flughafen Wien Aktiengesellschaft | 1.11B |
| Oberbank AG | 885.82M |